Modus Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,706
| Closed | -$7.09K | – | 106 |
|
|
2023
Q1 | $7.09K | Hold |
19,706
| – | – | ﹤0.01% | 102 |
|
|
2022
Q4 | $17.5K | Hold |
19,706
| – | – | 0.01% | 100 |
|
|
2022
Q3 | $31K | Hold |
19,706
| – | – | 0.02% | 93 |
|
|
2022
Q2 | $40K | Hold |
19,706
| – | – | 0.02% | 95 |
|
|
2022
Q1 | $46K | Hold |
19,706
| – | – | 0.02% | 97 |
|
|
2021
Q4 | $92K | Hold |
19,706
| – | – | 0.04% | 96 |
|
|
2021
Q3 | $150K | Hold |
19,706
| – | – | 0.06% | 98 |
|
|
2021
Q2 | $191K | Hold |
19,706
| – | – | 0.08% | 97 |
|
|
2021
Q1 | $163K | Buy |
19,706
+4,846
| +33% | +$40.1K | 0.08% | 94 |
|
|
2020
Q4 | $101K | Buy |
+14,860
| New | +$101K | 0.05% | 86 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$63K | – | 225 |
|
|
2020
Q2 | $63K | Buy |
+10,000
| New | +$63K | 0.04% | 108 |
|